ECP versus ruxolitinib in steroid-refractory acute GVHD – a retrospective study by the EBMT transplant complications working party by Olaf Penack, Olaf Penack, Christophe Peczynski, Christophe Peczynski, William Boreland, William Boreland, Jessica Lemaitre, Jessica Lemaitre, Ksenia Afanasyeva, Brian Kornblit, Manuel Jurado, Carmen Martinez, Annalisa Natale, Jose Antonio Pérez-Simón, Lucia Brunello, Daniele Avenoso, Stefan Klein, Zubeyde Nur Ozkurt, Concha Herrera, Stina Wichert, Patrizia Chiusolo, Eleni Gavriilaki, Grzegorz W. Basak, Grzegorz W. Basak, Hélène Schoemans, Hélène Schoemans, Christian Koenecke, Christian Koenecke, Ivan Moiseev, Zinaida Peric, Zinaida Peric

Subjects: Get full text

Case report: Durable response to ruxolitinib in a child with TREX1-related disorder by Yasir Bin Khathlan, Sajdi Almutairi, Fahad B. Albadr, Abdullah A. Alangari, Abdulrahman Alsultan, Abdulrahman Alsultan

Subjects: Get full text